Literature DB >> 12093781

Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts.

Hendrik T Tevaearai1, Andrea D Eckhart, G Brant Walton, Janelle R Keys, Katrina Wilson, Walter J Koch.   

Abstract

BACKGROUND: Mechanical assistance of the failing left ventricle (LV) can lead to functional recovery after a period of unloading, including restoration of beta-adrenergic receptor (betaAR) inotropic reserve. We tested whether prolonged LV unloading of failing rabbit hearts by use of a heterotopic transplantation technique could lead to recovery and whether adenoviral gene transfer of a beta2AR transgene (Adv-beta2AR) could alter this process. METHODS AND
RESULTS: Heart failure was induced by coronary artery ligation in adult New Zealand White rabbits. After 4 weeks, failing hearts were heterotopically transplanted into recipient rabbits, allowing normal coronary perfusion but complete LV unloading. We also placed an LV latex balloon for remote access and in vivo physiological analysis. We found that there was reversal of signaling and functional abnormalities after 30 days of unloading. In another set of failing hearts, we randomly delivered, at the time of transplantation, either 2x10(11) viral particles of Adv-beta2AR or saline via the coronary arteries. Sham-operated animals with nonfailing hearts served as controls. After 5 days of unloading, in vivo LV contractility (LV dP/dt(max)) and relaxation (LV dP/dt(min)) were significantly decreased in saline-treated failing hearts compared with control nonfailing hearts (P<0.05). In failing hearts treated with Adv-beta2AR, however, LV dP/dt(max) and LV dP/dt(min) were improved in response to higher preloads (P<0.05) and betaAR stimulation (P<0.01).
CONCLUSIONS: Heterotopic transplantation in the rabbit does allow recovery of the failing heart, and beta2AR overexpression acutely enhances this functional improvement. Accordingly, genetic manipulation of betaAR signaling may represent a novel molecular adjunct to mechanical assistance to facilitate functional myocardial recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093781     DOI: 10.1161/01.cir.0000020220.79105.fd

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

Review 1.  Calcium cycling proteins and their association with heart failure.

Authors:  L Hadri; R J Hajjar
Journal:  Clin Pharmacol Ther       Date:  2011-08-10       Impact factor: 6.875

Review 2.  Gene therapy in heart failure.

Authors:  Leif Erik Vinge; Philip W Raake; Walter J Koch
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

Review 3.  betaARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease.

Authors:  Henriette Brinks; Walter J Koch
Journal:  J Cardiovasc Transl Res       Date:  2010-07-10       Impact factor: 4.132

Review 4.  Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

Authors:  Stephen F Vatner; Misun Park; Lin Yan; Grace J Lee; Lo Lai; Kousaku Iwatsubo; Yoshihiro Ishikawa; Jeffrey Pessin; Dorothy E Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-26       Impact factor: 4.733

Review 5.  Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.

Authors:  David Ho; Lin Yan; Kousaku Iwatsubo; Dorothy E Vatner; Stephen F Vatner
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

6.  Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure.

Authors:  G Rengo; C Zincarelli; G D Femminella; D Liccardo; G Pagano; C de Lucia; G G Altobelli; V Cimini; D Ruggiero; P Perrone-Filardi; E Gao; N Ferrara; A Lymperopoulos; W J Koch; D Leosco
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 7.  Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action.

Authors:  Stavros G Drakos; Abdallah G Kfoury; Craig H Selzman; Divya Ratan Verma; John N Nanas; Dean Y Li; Josef Stehlik
Journal:  Curr Opin Cardiol       Date:  2011-05       Impact factor: 2.161

Review 8.  Adrenergic signaling in heart failure and cardiovascular aging.

Authors:  Gaetano Santulli; Guido Iaccarino
Journal:  Maturitas       Date:  2016-03-26       Impact factor: 4.342

9.  Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers.

Authors:  Brian D Lowes; Ronald Zolty; Simon F Shakar; Andreas Brieke; Norman Gray; Michael Reed; Mihail Calalb; Wayne Minobe; JoAnn Lindenfeld; Eugene E Wolfel; Mark Geraci; Michael R Bristow; Joseph Cleveland
Journal:  J Heart Lung Transplant       Date:  2007-11       Impact factor: 10.247

Review 10.  Genetics and pharmacogenetics in heart failure.

Authors:  Eric M Snyder; Thomas P Olson; Bruce D Johnson
Journal:  Curr Heart Fail Rep       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.